McKesson

Cardinal Health

CMS Energy

Healthcare and Utilities Sectors Lead in Thursday Trading

McKesson Raises Guidance After Q3 Earnings, Sees 17-19% YoY EPS Growth

McKesson shares surge 16% as earnings rise to $1.186 billion

The Estee Lauder

STERIS

McKesson Leads S&P 500 Gainers, Estee Lauder Among Losers.

McKesson Reports Strong Q3 Earnings, Raises Guidance, and Advances Medical-Surgical Separation Plans

Catalyst<ul> <li>Bullish signals are obviously dominant with three bullish versus one bearish technical indicators recently observed for MCK.</li> <li>The company maintains strong cash reserves relative to market value according to fundamental analysis.</li> <li>Most analysts rate MCK Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough for MCK.</li> <li>Fund flow analysis indicates an overall negative trend despite some positive inflows from small and extra-large orders.</li> <li>At least one major firm maintains a Neutral rating citing valuation concerns.</li></ul>

Key Factors

McKesson's Q3 2026 adjusted EPS beat estimates by 0.3% at $9.34, with revenue rising 11% to $106.2 billion.McKesson's stock surged ~16% following its Q3 earnings report, which exceeded expectations.McKesson raised its full-year 2026 EPS guidance to $38.80–$39.20 and plans to return $2.5 billion via buybacks.

Recent Updates

MCK News